LGM Pharma: LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semisolid & suppository drug products
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its
Read full article »
LGM Pharma engages in the research, development and distribution of Cyclic Guanosine Monophosphate ingredients to pharmaceutical companies.
Read more